Big Announcement Alert: Discoveries meet momentum. Right here.

Fitzsimon_menu

Filter by

Fitzsimons Innovation Community Growing as Life Sciences Hub in Aurora
News | Jun 24, 2022

Fitzsimons Innovation Community Growing as Life Sciences Hub in Aurora

The plan calls for 45 thousand jobs at full buildout. Already there is a $10 Billion dollar annual economic impact in a single square mile....

US-Based Biotechnology Company, Taiga Launches Breakthrough Veterinary Cancer Treatment in Singapore
News | Apr 29, 2022

US-Based Biotechnology Company, Taiga Launches Breakthrough Veterinary Cancer Treatment in Singapore

Taiga Biotechnologies, a clinical-stage biotechnology company focused on harnessing the power of the immune system to fight solid tumors and infectious disease...

Fitzsimons Innovation Community Welcomes Four New Board Members
News | Apr 28, 2022

Fitzsimons Innovation Community Welcomes Four New Board Members

Comprised of leaders representing the bioscience industry, University of Colorado, and the City of Aurora, the Board of Directors supports the vision of Fitzsimons Innovation Community.

26 Top BioPharma Startups & Companies (Colorado)
News | Apr 25, 2022

26 Top BioPharma Startups & Companies (Colorado)

BioPharma companies have been making some huge strides over the last year with innovations driven by both established players and startups entering the scene. With an impressive 7.32% CAGR and a value of $325.17 billion in 2020 it is a huge industry ripe for growth.

CU School of Medicine Research Sparks Call-to-Action on Treating In-Hospital Stroke
News | Feb 24, 2022

CU School of Medicine Research Sparks Call-to-Action on Treating In-Hospital Stroke

CU SOM professor’s decade of research serves as backbone for improved care guidelines

Colorado Life Sciences Companies Raise a Record $2.4 Billion in 2021
News | Dec 14, 2021

Colorado Life Sciences Companies Raise a Record $2.4 Billion in 2021

Colorado’s life sciences ecosystem raised $2.4 billion in 2021, a new record for the fast-growing community that includes companies at all stages of commercialization and academic and research institutions. The 2021 fundraising total is double the $1.2 billion raised by the Colorado life sciences community in 2020. Sources of funding included headline-making IPOs, significant additional capital raised in public markets, an infusion of venture capital, and grants from federal and state sources.

Fitzsimons Innovation Community First Annual Innovation Report: “United to Advance Health”
News | Dec 09, 2021

Fitzsimons Innovation Community First Annual Innovation Report: “United to Advance Health”

New report demonstrates Community momentum to meet speed-to-market urgency in biotech.

European Medicines Agency (EMA) Validates Atara Biotherapeutics' Marketing Authorization Application
News | Nov 30, 2021

European Medicines Agency (EMA) Validates Atara Biotherapeutics' Marketing Authorization Application

Atara Biotherapeutics announced that the Marketing Authorization Application (MAA) for tabelecleucel (tab-cel®) has been fully validated by the European Medicines Agency (EMA).

Pathways Bioscience Seeks to Optimize Aging
News | Nov 30, 2021

Pathways Bioscience Seeks to Optimize Aging

Pathways Bioscience’s technology improves healthspan and overcomes health and wellness problems associated with aging.

Two CU Cancer Center Members Recognized as World Experts in Pancreatic Neoplasms
News | Nov 19, 2021

Two CU Cancer Center Members Recognized as World Experts in Pancreatic Neoplasms

Expertscape rankings recognize Richard Schulick, MD, and Marco Del Chiaro, MD, among the top 0.1% of scholars worldwide.

Taiga Initiates Phase 1/2 Clinical Study of TBX-2400 in Acute Myeloid Leukemia and Myelofibrosis in Croatia
News | Nov 10, 2021

Taiga Initiates Phase 1/2 Clinical Study of TBX-2400 in Acute Myeloid Leukemia and Myelofibrosis in Croatia

TBX-2400 is expected to improve engraftment and reconstitution of immune system for patients receiving Hematopoietic Stem Cell Transplants.

Pharmaceutical Executive Podcast
News | Oct 28, 2021

Pharmaceutical Executive Podcast

Amie Krause, Senior Vice President and Chief People Officer, and Kristin Yarema, Chief Commercial Officer, of Atara Biotherapeutics, discuss women in leadership positions in pharma and the effects of a gender diverse company.